MSB vs REG

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

38LOW

REG

REG HEALTH FPO [REG]

38LOW

Score Breakdown

MSB REG
Technical
55
61
Catalyst
54
50
Sentiment
50
50
Fundamental
66
89
Momentum
67
50
Risk Gate
40
47

Key Metrics

MSB Metric REG
$2.7BMarket Cap$2.0B
4.4MAvg Volume (20d)601K
+8.3%Short Interest+1.1%
$3.31052-Week High$9.400
$1.51552-Week Low$5.800
+6.3%Daily Change+4.3%
$2.190Entry Price$6.510
-18.2%ROEN/A
-144.3%Profit Margin+3.0%

Active Signals

MSB Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

REG Signals

●Above-average volume (1.7x) on a green day — buyers stepping up
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.6x)
●Moderate revenue growth (+18%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare MSB and REG in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MSB Full Analysis → REG Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).